Skip to content

Advertisement

Open Peer Review Reports for: Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
29 Nov 2016 Submitted Original manuscript
30 Jan 2017 Reviewed Reviewer Report - Johannes Nossent
3 Mar 2017 Reviewed Reviewer Report - William Rigby
26 Mar 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 2
26 Mar 2017 Submitted Manuscript version 2
30 Mar 2017 Reviewed Reviewer Report - Johannes Nossent
24 Apr 2017 Reviewed Reviewer Report - William Rigby
21 May 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 3
21 May 2017 Submitted Manuscript version 3
25 May 2017 Reviewed Reviewer Report - Johannes Nossent
17 Jun 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 4
17 Jun 2017 Submitted Manuscript version 4
Publishing
13 Jul 2017 Editorially accepted
19 Jul 2017 Article published 10.1186/s12891-017-1673-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement